StockTipsArenaBeta

SELL Laurus Labs Ltd — Goldman Sachs

SELLLaurus Labs Ltd
Laurus Labs share price target & all analyst calls

byGoldman SachsHorizon: NA (inferred 1 year)25 Sept 2026via ET Now (Live)

Entry₹2,026Inferred
Target₹1,250
Total upside +38.30%
Stop lossNot given
CMP₹2,4241d ago
Active-19.64%+48.43%upside left 10 mo left
Follow Goldman Sachs for new calls(100% target hit, 47 closed calls)Get alertsWatch LAURUSLABS for new buy/sell callsGet alertsSee 9 other Long-term calls on LAURUSLABSSee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:24 am IST
1 supporting16 neutral30 opposing
Supports the SELL call (1)

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·30 Oct · 2w ago

Neutral / worth noting (16)

Sensex, Nifty extend gains for 2nd day: IT stocks lead rally, broader market underperforms

NewsCnbc-Tv18·30 Oct · 2w ago

(opens in new tab)

Laurus Labs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·29 Oct · 2w ago

(opens in new tab)
Weighs against the SELL call (30)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

Laurus Labs share price at record high after Q2 results 20⁠⁩26, dividend announcement - Should you buy pharma stock?

NewsLivemint·30 Oct · 2w ago

(opens in new tab)

Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY

NewsEt-Markets·30 Oct · 2w ago

(opens in new tab)

Laurus Labs hits 52-week high as strong Q2 results fuel buying

NewsHbl·30 Oct · 2w ago

(opens in new tab)

Laurus Labs Q2 Review: Brokerages Split As Jefferies Raises Target, Two Retain Sell

NewsNdtv-Profit·30 Oct · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Laurus Labs

All analyst calls on Laurus Labs

More from Goldman Sachs

Every call and its outcome